Fava, M
Fava, M
Massachusetts General Hospital and Harvard Medical School
Verified email at
Cited by
Cited by
Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR* D report
AJ Rush, MH Trivedi, SR Wisniewski, AA Nierenberg, JW Stewart, ...
American Journal of Psychiatry 163 (11), 1905-1917, 2006
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR* D: implications for clinical practice
MH Trivedi, AJ Rush, SR Wisniewski, AA Nierenberg, D Warden, L Ritz, ...
American journal of Psychiatry 163 (1), 28-40, 2006
Diagnosis and definition of treatment-resistant depression
M Fava
Biological psychiatry 53 (8), 649-659, 2003
Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression
AJ Rush, MH Trivedi, SR Wisniewski, JW Stewart, AA Nierenberg, ...
New England Journal of Medicine 354 (12), 1231-1242, 2006
Medication augmentation after the failure of SSRIs for depression
MH Trivedi, M Fava, SR Wisniewski, ME Thase, F Quitkin, D Warden, ...
New England Journal of Medicine 354 (12), 1243-1252, 2006
Major depressive disorder
C Otte, SM Gold, BW Penninx, CM Pariante, A Etkin, M Fava, DC Mohr, ...
Nature reviews Disease primers 2 (1), 1-20, 2016
A mega-analysis of genome-wide association studies for major depressive disorder
Major Depressive Disorder Working Group of the Psychiatric GWAS Consortium
Molecular psychiatry 18 (4), 2013
Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder
DA Pizzagalli, AJ Holmes, DG Dillon, EL Goetz, JL Birk, R Bogdan, ...
American Journal of Psychiatry 166 (6), 702-710, 2009
Sequenced treatment alternatives to relieve depression (STAR* D): rationale and design
AJ Rush, M Fava, SR Wisniewski, PW Lavori, MH Trivedi, HA Sackeim, ...
Controlled clinical trials 25 (1), 119-142, 2004
Definition and epidemiology of treatment-resistant depression
M Fava, KG Davidson
Psychiatric Clinics of North America 19 (2), 179-200, 1996
Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR* D report
M Fava, AJ Rush, JE Alpert, GK Balasubramani, SR Wisniewski, ...
American Journal of Psychiatry 165 (3), 342-351, 2008
Depression and public health: an overview
P Cassano, M Fava
Journal of psychosomatic research 53 (4), 849-857, 2002
Major depressive disorder
M Fava, KS Kendler
Neuron 28 (2), 335-341, 2000
Remissions in maternal depression and child psychopathology: a STAR* D-child report
MM Weissman, DJ Pilowsky, PJ Wickramaratne, A Talati, SR Wisniewski, ...
Jama 295 (12), 1389-1398, 2006
Reduced hedonic capacity in major depressive disorder: evidence from a probabilistic reward task
DA Pizzagalli, D Iosifescu, LA Hallett, KG Ratner, M Fava
Journal of psychiatric research 43 (1), 76-87, 2008
Report by the ACNP Task Force on response and remission in major depressive disorder
AJ Rush, HC Kraemer, HA Sackeim, M Fava, MH Trivedi, E Frank, ...
Neuropsychopharmacology 31 (9), 1841-1853, 2006
The STAR* D Project results: a comprehensive review of findings
D Warden, AJ Rush, MH Trivedi, M Fava, SR Wisniewski
Current psychiatry reports 9 (6), 449-459, 2007
Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial
JF Rosenbaum, M Fava, SL Hoog, RC Ascroft, WB Krebs
Biological psychiatry 44 (2), 77-87, 1998
STAR* D: what have we learned?
AJ Rush
American Journal of Psychiatry 164 (2), 201-204, 2007
Background and rationale for the sequenced treatment alternatives to relieve depression (STAR∗ D) study
M Fava, AJ Rush, MH Trivedi, AA Nierenberg, ME Thase, HA Sackeim, ...
Psychiatric Clinics 26 (2), 457-494, 2003
The system can't perform the operation now. Try again later.
Articles 1–20